Biophysics in Drug Discovery 2019 | European Edition
Developing the Synergy between Biophysics and Medicinal Chemistry to Deliver Better Drugs
Cannes, France March 20-22, 2019
NovAliX & Ribostruct, Illkirch, France
GlaxoSmithKline, Stevenage, United Kingdom
Uppsala University, Uppsala, Sweden
Bayer, Berlin, Germany
Merck, Darmstadt, Germany
AstraZeneca, Mölndal, Sweden
leadXpro, Villigen, Switzerland
F. Hoffmann-La Roche, Basel, Switzerland
Novartis, Basel, Switzerland
Boehringer Ingelheim, Biberach, Germany